慢性缩性胃炎的机制:20年的图书识别分析
Yun-Kai Dai1, Dan-Yan Li2, Long-Ling Cong1
1Department of Gastroenterology, The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangzhou, Guangdong, 510130, People's Republic of China.
Journal of inflammation research
|December 22, 2025
概括
这份图书统计分析绘制了20年慢性缩性胃炎 (CAG) 研究的地图,揭示了关键主题和合作. 这些发现指导了对CAG机制和胃癌预防的未来研究.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 图书统计学 图书统计学
背景情况:
- 慢性缩性胃炎 (CAG) 影响高风险人群的20-30%,增加胃癌的风险.
- 尽管进行了广泛的研究,但CAG病原学文献缺乏系统的映射.
- 需要进行全面的文献识别分析,以了解该领域的演变,并识别知识差距.
研究的目的:
- 进行长期缩性胃炎 (CAG) 研究的20年文献分析 (2005-2024年).
- 识别CAG病原体的开创性工作,新兴主题和知识差距.
- 评估全球协作网络,并突出CAG研究中的翻译挑战.
主要方法:
- 来自Web of Science核心集合 (2005-2024) 的954篇论文的图书统计分析.
- 使用CiteSpace和VOSviewer分析出版趋势,作者,机构和关键词.
- 检查了关键词集群和引文爆发,以确定研究热点.
主要成果:
- 在CAG出版物方面,中国领先 (41.51%),其次是美国 (15.20%).
- 美国在国际研究合作中发挥着高度的中心作用.
- 关键的研究主题包括Helicobacter pylori,中国传统医学,巨细胞生物学和胃肠道转化等.
结论:
- 对于慢性缩性胃炎 (CAG) 存在重大的全球研究成果和合作.
- 跨学科的方法和国际伙伴关系对于推进CAG研究至关重要.
- 未来的研究应该将传统知识与机械学研究相结合,并探索微生物组失调和精确医学,以预防胃癌.
相关概念视频
01:17Gastritis-II: Pathophysiology
1.1K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K
01:27Gastritis-I: Introduction and Types
2.1K
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
2.1K
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
1.1K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.1K
01:28Peptic Ulcer Disease II: Pathophysiology
1.8K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.8K
01:23Gastritis III: Clinical Manifestations and Management
1.1K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.1K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K